Jasper Therapeutics announces 1-for-10 reverse stock split effective Jan 4, 2024

Jasper Therapeutics, Inc.

Reverse split ratio set at 1-for-10, effective 12:01 a.m. ET on Jan 4, 2024.
Outstanding shares reduced from ~111.6M to ~11.2M; par value unchanged.
Intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement.
No fractional shares; cash in lieu based on Jan 3 closing price.
Warrants adjusted: 10 warrants exercisable for 1 share at $115.00 per share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.